Streptomyces hygroscopicus subsp. hygroscopicus (Jensen) Waksman and Henrici
商品貨號(hào)
B241160
Strain Designations
FD 28576 [N 787-182]
Application
Produces C-13 beta-acyloxymilbemycins
Produces N787-182 complex
Isolation
Soil, Kurashiki City, Okayama Pref., Japan
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 172: N-Z amine with soluble starch and glucose
Haxell MA, et al. C-13 beta-acyloxymilbemycins, a new family of macrolides. Discovery, structural determination and biological properties. J. Antibiot. 45: 659-670, 1992. PubMed: 1624368
Haxell MA, et al. Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds. US Patent 5,573,946 dated Nov 12 1996
Haxell MA, et al. Process for producing antiparasitic macrolide antibiotics. US Patent 5,589,366 dated Dec 31 1996
